MFGE8 and metastatic malignant neoplasm: MFGE8 did not directly increase MDSC effector molecule expression, but MDSC-derived MFGE8 promoted the metastasis of B16F10 melanoma cells, suggesting that MDSC-derived MFGE8 could be a promising target for metastatic cancer therapies.